Closed-ended linear duplex DNA for non-viral gene transfer
US12252703B2 · kind B2 · utility
0Cited by
5References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 1, 2021 |
| Grant date | Mar 18, 2025 |
| Priority date | — |
| Expiry date | Jun 28, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14151
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Aspects of the disclosure relate to a nucleic acid comprising a heterologous nucleic acid insert flanked by interrupted self-complementary sequences, wherein one self-complementary sequence is interrupted by a cross-arm sequence forming two opposing, lengthwise-symmetric stem-loops, and wherein the other of the self-complementary sequences is interrupted by a truncated cross-arm sequence. Methods of delivering the nucleic acid to a cell are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.